(Q59359632)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29876771%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

title

Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29876771%20AND%20SRC:MED&resulttype=core&format=json

respiratory syncytial virus

30 March 2020

main subject

object named as

Human respiratory syncytial virus

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29876771%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Hadi M Yassine

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29876771%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

author name string

Asmaa A Al Thani

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29876771%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

Khalid Al Ansari

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29876771%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

language of work or name

English

0 references

publication date

6 June 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29876771%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Microbiology & Infectious Diseases

30 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29876771%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29876771%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29876771%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

page(s)

1817-1827

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29876771%20AND%20SRC:MED&resulttype=core&format=json

Two distinct subtypes of human respiratory syncytial virus

30 March 2020

cites work

1 reference

12 December 2020

Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity.

1 reference

12 December 2020

Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function

1 reference

12 December 2020

Nucleotide sequences for the gene junctions of human respiratory syncytial virus reveal distinctive features of intergenic structure and gene order

1 reference

12 December 2020

Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein

1 reference

12 December 2020

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

12 December 2020

Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

12 December 2020

Safety and effectiveness of the new inactivated hepatitis A virus vaccine.

1 reference

12 December 2020

Clinical experience with an inactivated hepatitis A vaccine

1 reference

12 December 2020

Human monoclonal antibodies isolated from spontaneous Epstein-Barr virus-transformed tumors of Hu-SPL-SCID mice and specific for fusion protein display broad neutralizing activity toward respiratory syncytial virus

1 reference

12 December 2020

Respiratory syncytial virus infection

1 reference

12 December 2020

Structural characterization of the human respiratory syncytial virus fusion protein core

1 reference

12 December 2020

CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein

1 reference

12 December 2020

Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology

1 reference

12 December 2020

Recovery of cytopathogenic agent from chimpanzees with coryza

1 reference

12 December 2020

SURVIVAL OF THE RESPIRATORY SYNCYTIAL VIRUS DURING STORAGE UNDER VARIOUS CONDITIONS

1 reference

12 December 2020

Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy.

1 reference

12 December 2020

The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin

1 reference

12 December 2020

Growth of respiratory syncytial virus in primary epithelial cells from the human respiratory tract

1 reference

12 December 2020

Epidemiology and clinical characteristics of respiratory syncytial virus infections in Jordan

1 reference

12 December 2020

A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines

1 reference

12 December 2020

Immunopathology of RSV infection: prospects for developing vaccines without this complication

1 reference

12 December 2020

The histopathology of fatal untreated human respiratory syncytial virus infection

1 reference

12 December 2020

Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth

1 reference

12 December 2020

Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses

1 reference

12 December 2020

Viral and host factors in human respiratory syncytial virus pathogenesis

1 reference

12 December 2020

Regulation of immunity to respiratory syncytial virus by dendritic cells, toll-like receptors, and notch

1 reference

12 December 2020

The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes

1 reference

12 December 2020

Human genetic factors and respiratory syncytial virus disease severity

1 reference

12 December 2020

Cigarette smoke alters respiratory syncytial virus-induced apoptosis and replication

1 reference

12 December 2020

Infant exposure to fine particulate matter and traffic and risk of hospitalization for RSV bronchiolitis in a region with lower ambient air pollution

1 reference

12 December 2020

A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction

1 reference

12 December 2020

B-cell responses to vaccination at the extremes of age.

1 reference

12 December 2020

From the American Academy of Pediatrics: Policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections

1 reference

12 December 2020

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

1 reference

12 December 2020

Viral load drives disease in humans experimentally infected with respiratory syncytial virus

1 reference

12 December 2020

Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans.

1 reference

12 December 2020

Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice

1 reference

12 December 2020

Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis

1 reference

12 December 2020

Characterization of the interaction between human respiratory syncytial virus and the cell cycle in continuous cell culture and primary human airway epithelial cells

1 reference

12 December 2020

Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2.

1 reference

12 December 2020

Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention

1 reference

12 December 2020

Pathogenesis of respiratory syncytial virus

1 reference

12 December 2020

Prevalence of Acute Lower Respiratory Tract Infections due to Respiratory Syncytial Virus in Amirkola Children's hospital, Northern Iran during March 2008-March 2010

1 reference

12 December 2020

Strategic priorities for respiratory syncytial virus (RSV) vaccine development

1 reference

12 December 2020

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

1 reference

12 December 2020

Molecular characterization of circulating respiratory syncytial virus (RSV) genotypes in Gilgit Baltistan Province of Pakistan during 2011-2012 winter season

1 reference

12 December 2020

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

1 reference

12 December 2020

The adaptive immune response to respiratory syncytial virus

1 reference

12 December 2020

Respiratory syncytial virus mechanisms to interfere with type 1 interferons

1 reference

12 December 2020

Consequences of immature and senescent immune responses for infection with respiratory syncytial virus

1 reference

12 December 2020

The mouse model of respiratory syncytial virus disease.

1 reference

12 December 2020

Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children

1 reference

12 December 2020

Quantitative and qualitative deficits in neonatal lung-migratory dendritic cells impact the generation of the CD8+ T cell response

1 reference

12 December 2020

Respiratory syncytial virus: current and emerging treatment options

1 reference

12 December 2020

Ontogeny of early life immunity

1 reference

12 December 2020

Limited type I interferons and plasmacytoid dendritic cells during neonatal respiratory syncytial virus infection permit immunopathogenesis upon reinfection.

1 reference

12 December 2020

The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants.

1 reference

12 December 2020

Immune responses in neonates

1 reference

12 December 2020

Inhibition of the Human Respiratory Syncytial Virus Small Hydrophobic Protein and Structural Variations in a Bicelle Environment

1 reference

12 December 2020

Targeting regulatory T cells to improve vaccine immunogenicity in early life

1 reference

12 December 2020

Immunity to RSV in Early-Life.

1 reference

12 December 2020

Is Infant Immunity Actively Suppressed or Immature?

1 reference

12 December 2020

Immunology of bovine respiratory syncytial virus in calves.

1 reference

12 December 2020

Challenges and opportunities in developing respiratory syncytial virus therapeutics

1 reference

12 December 2020

RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets

1 reference

12 December 2020

Control of adaptive immunity by the innate immune system

1 reference

12 December 2020

Novel antigens for RSV vaccines

1 reference

12 December 2020

WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015.

1 reference

12 December 2020

Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein

1 reference

12 December 2020

The changing landscape of respiratory syncytial virus

1 reference

12 December 2020

Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections

1 reference

12 December 2020

A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

1 reference

12 December 2020

Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera

1 reference

12 December 2020

A Numerically Subdominant CD8 T Cell Response to Matrix Protein of Respiratory Syncytial Virus Controls Infection with Limited Immunopathology

1 reference

12 December 2020

Determinants of early life immune responses to RSV infection

1 reference

12 December 2020

Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV

1 reference

12 December 2020

Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins

1 reference

12 December 2020

A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant

1 reference

12 December 2020

Vaccines against respiratory syncytial virus: The time has finally come

1 reference

12 December 2020

Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung.

1 reference

12 December 2020

Design and validation of small interfering RNA on respiratory syncytial virus M2-2 gene: A potential approach in RNA interference on viral replication

1 reference

12 December 2020

Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus.

1 reference

12 December 2020

Overview of Vaccine Adjuvants: Introduction, History, and Current Status

1 reference

12 December 2020

Nucleoside Modified mRNA Vaccines for Infectious Diseases

1 reference

12 December 2020

Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors

1 reference

12 December 2020

A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein

1 reference

12 December 2020

Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design

1 reference

12 December 2020

Vaccine development for respiratory syncytial virus

1 reference

12 December 2020

Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater In Vivo Protection than the Murine Precursor of Palivizumab

1 reference

12 December 2020

Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.

1 reference

12 December 2020

Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F

1 reference

12 December 2020

Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus

1 reference

12 December 2020

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein.

1 reference

12 December 2020

Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.

1 reference

12 December 2020

10.1007/S10096-018-3289-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29876771%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

1 reference